Обзор американских кардиологических журналов за неделю (ссылки)

[Chevychelov]

Аритмии
[Ссылки доступны только зарегистрированным пользователям ]
Сердечно-сосудистая хирургия
[Ссылки доступны только зарегистрированным пользователям ]
Врожденные пороки сердца
[Ссылки доступны только зарегистрированным пользователям ]
Общая кардиология
[Ссылки доступны только зарегистрированным пользователям ]
Сердечная недостаточность/трансплантация
[Ссылки доступны только зарегистрированным пользователям ]
Интервенционная кардиология
[Ссылки доступны только зарегистрированным пользователям ]
Неинвазивная кардиология
[Ссылки доступны только зарегистрированным пользователям ]
Профилактика/сосуды
[Ссылки доступны только зарегистрированным пользователям ]

Defibrillator Implantation Early After Myocardial Infarction
Steinbeck G, Andresen D, Seidl K, et al., on behalf of the IRIS Investigators.
N Engl J Med 2009;361:1427-1436.
Study Question: Do implantable cardioverter defibrillators (ICDs) improve survival when implanted in high-risk patients within 1 month of a myocardial infarction (MI)?
[Ссылки доступны только зарегистрированным пользователям ]

Long-Term Results of Catheter-Based Treatment of Pulmonary Atresia and Intact Ventricular Septum
Marasini M, Gorrieri PF, Tuo G, et al.
Heart 2009;95:1520-1524.
Study Question: What are the outcomes of patients with pulmonary atresia with intact ventricular septum (PAIVS) after interventional perforation of the pulmonary valve?
[Ссылки доступны только зарегистрированным пользователям ]

A Meta-Analysis of Remote Monitoring of Heart Failure Patients
Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A.
J Am Coll Cardiol 2009;54:1683-1694.
Study Question: What is the effect of remote patient monitoring (RPM) on the outcome of chronic heart failure (HF) patients?
[Ссылки доступны только зарегистрированным пользователям ]

Hospitalizations After Heart Failure Diagnosis: A Community Perspective
Dunlay SM, Redfield MM, Weston SA, et al.
J Am Coll Cardiol 2009;54:1695-1702.
Study Question: What is the lifetime burden and risk factors for hospitalization after heart failure (HF) diagnosis in the community?
[Ссылки доступны только зарегистрированным пользователям ]

Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
Mazzaglia G, Ambrosioni E, Alacqua M, et al.
Circulation 2009;120:1598-1605.
Study Question: What are the predictors of adherence to antihypertensive treatment and the association of adherence with acute cardiovascular events?
[Ссылки доступны только зарегистрированным пользователям ]

Neighborhood Resources for Physical Activity and Healthy Foods and Incidence of Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis
Auchincloss AH, Diez Roux AV, Mujahid MS, et al.
Arch Intern Med 2009;169:1698-1704.
Study Question: Are neighborhood resources associated with incidence of type 2 diabetes mellitus (DM)?
[Ссылки доступны только зарегистрированным пользователям ]

C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-Analyses for the U.S. Preventive Services Task Force
Buckley DI, Fu R, Freeman M, Rogers K, Helfand M.
Ann Intern Med 2009;151:483-495.
Study Question: C-reactive protein (CRP) may help to refine global risk assessment for coronary heart disease (CHD), particularly among persons who are at intermediate risk on the basis of traditional risk factors alone. Should CRP be incorporated into guidelines for CHD risk assessment?
[Ссылки доступны только зарегистрированным пользователям ]

Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Helfand M, Buckley DI, Freeman M, et al.
Ann Intern Med 2009;151:496-507.
Study Question: Traditional risk factors do not explain all of the risk for incident coronary heart disease (CHD) events. What is the evidence of value of new or emerging risk factors for improving global risk assessment for CHD?
[Ссылки доступны только зарегистрированным пользователям ]

Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events
Wong ND, Gransar H, Narula J, et al.
JACC Cardiovasc Img 2009;2:1093-1099.
Study Question: Myeloperoxidase (MPO) is a leukocyte-derived enzyme-generating reactive oxidant species that has been shown to predict risk of cardiovascular disease (CVD) in selected populations. Does MPO predict future CVD events in asymptomatic adults, and does subclinical atherosclerosis affect this relation?
[Ссылки доступны только зарегистрированным пользователям ]

Vardenafil Treatment for Patients With Pulmonary Arterial Hypertension: A Multicentre, Open-Label Study
Jing ZC, Jiang X, Wu BX, et al.
Heart 2009;95:1531-1536.
Study Question: What are the long-term effects of vardenafil, a phosphodiesterase-5 (PDE-5) inhibitor, in patients with pulmonary arterial hypertension (PAH)?
[Ссылки доступны только зарегистрированным пользователям ]